ADPT — Adaptogenics Health Balance Sheet
0.000.00%
- CA$0.57m
- CA$0.47m
- CA$0.00m
Annual balance sheet for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.534 | 0.262 | 0.149 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.004 | 0.004 | 0.005 |
Prepaid Expenses | |||
Total Current Assets | 0.578 | 0.303 | 0.154 |
Total Assets | 0.578 | 0.303 | 0.154 |
Payable / Accrued | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.048 | 0.039 | 0.022 |
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 0.048 | 0.039 | 0.022 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 0.529 | 0.264 | 0.132 |
Total Liabilities & Shareholders' Equity | 0.578 | 0.303 | 0.154 |
Total Common Shares Outstanding |